Ha habido 50 transacciones internas recientes registradas para SAB Biotherapeutics, Inc. (SABS), incluyendo 38 compras y 8 ventas. El total de compras internas fue valorado en $151.56M y el total de ventas internas en $180.65K.
Internos destacados con actividad reciente incluyen Kropotova Alexandra, Reich Samuel J, Sullivan Eddie Joe. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — SABS
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-24 |
Kropotova Alexandra |
Chief Medical Officer |
Retención Fiscal de RSU |
988 |
- |
- |
43,296 |
| 2026-02-03 |
Reich Samuel J |
CEO |
Concesión de RSU |
4,800,000 |
$4.45 |
$21.36M |
4,800,000 |
| 2026-02-03 |
Kropotova Alexandra |
Chief Medical Officer |
Concesión de RSU |
2,400,000 |
$4.45 |
$10.68M |
2,400,000 |
| 2026-02-03 |
Sullivan Eddie Joe |
President |
Concesión de RSU |
3,000,000 |
$4.45 |
$13.35M |
3,000,000 |
| 2026-02-03 |
Bausch Christoph Lawrence |
Chief Operating Officer |
Concesión de RSU |
1,800,000 |
$4.45 |
$8.01M |
1,800,000 |
| 2026-02-03 |
To Lucy |
See Remarks |
Concesión de RSU |
2,400,000 |
$4.45 |
$10.68M |
2,400,000 |
| 2026-01-05 |
Zaccardelli David |
Officer |
Desconocido |
- |
- |
- |
- |
| 2026-01-05 |
Zaccardelli David |
Director |
Concesión de RSU |
240,000 |
$3.74 |
$897.6K |
240,000 |
| 2026-01-05 |
Jain Rita |
Officer |
Desconocido |
- |
- |
- |
- |
| 2026-01-05 |
Jain Rita |
Director |
Concesión de RSU |
240,000 |
$3.74 |
$897.6K |
240,000 |
| 2025-12-16 |
Skyler Jay S |
Director |
Concesión de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Lucera Erick |
Director |
Concesión de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Polvino William James |
Director |
Concesión de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Giberson Scott |
Director |
Concesión de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Ellias Helen K. |
Director |
Concesión de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-16 |
Link David |
Director |
Concesión de RSU |
150,000 |
$3.99 |
$598.5K |
150,000 |
| 2025-12-11 |
Kropotova Alexandra |
Chief Medical Officer |
Retención Fiscal de RSU |
988 |
- |
- |
44,284 |
| 2025-09-29 |
Sessa Capital (master), L.p. |
Director |
Ejercicio de Opciones (Venta) |
17,400 |
$1.75 |
$30.45K |
211,100 |
| 2025-09-29 |
Moin Andrew |
Director |
Ejercicio de Opciones (Venta) |
17,400 |
$1.75 |
$30.45K |
211,100 |
| 2025-09-19 |
Kropotova Alexandra |
Chief Medical Officer |
Retención Fiscal de RSU |
1,977 |
- |
- |
45,272 |
| 2025-08-26 |
Reich Samuel J |
CEO & Executive Chairman |
Concesión de RSU |
4,800,000 |
$2.17 |
$10.42M |
4,800,000 |
| 2025-08-26 |
Kropotova Alexandra |
Chief Medical Officer |
Concesión de RSU |
2,400,000 |
$2.17 |
$5.21M |
2,400,000 |
| 2025-08-26 |
Sullivan Eddie Joe |
President |
Concesión de RSU |
3,000,000 |
$2.17 |
$6.51M |
3,000,000 |
| 2025-08-26 |
Bausch Christoph Lawrence |
Chief Operating Officer |
Concesión de RSU |
600,000 |
$2.17 |
$1.3M |
600,000 |
| 2025-08-26 |
To Lucy |
See Remarks |
Concesión de RSU |
1,200,000 |
$2.17 |
$2.6M |
1,200,000 |
| 2025-07-22 |
Sessa Capital (master), L.p. |
Director |
Concesión de RSU |
114,250 |
$218.75 |
$24.99M |
114,250 |
| 2025-07-22 |
Moin Andrew |
Director |
Concesión de RSU |
114,250 |
$218.75 |
$24.99M |
114,250 |
| 2025-03-27 |
Kropotova Alexandra |
Chief Medical Officer |
Retención Fiscal de RSU |
1,179 |
- |
- |
47,249 |
| 2024-12-18 |
Kropotova Alexandra |
Chief Medical Officer |
Retención Fiscal de RSU |
9,072 |
- |
- |
48,428 |
| 2024-11-01 |
Ellias Helen K. |
Director |
Concesión de RSU |
20,000 |
$3.88 |
$77.6K |
20,000 |
| 2024-08-12 |
To Lucy |
See Remarks |
Concesión de RSU |
125,000 |
$2.35 |
$293.75K |
125,000 |
| 2024-07-26 |
To Lucy |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-07-15 |
Hamilton Christine E |
Director |
Concesión de RSU |
2,326 |
$2.90 |
$6.75K |
2,326 |
| 2024-07-15 |
Skyler Jay S |
Director |
Concesión de RSU |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-07-15 |
Reich Samuel J |
CEO & Executive Chairman |
Concesión de RSU |
35,700 |
$2.90 |
$103.53K |
35,700 |
| 2024-07-15 |
Spragens Jeffrey G |
Director |
Concesión de RSU |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-07-15 |
Lucera Erick |
Director |
Concesión de RSU |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-07-15 |
Polvino William James |
Director |
Concesión de RSU |
13,958 |
$2.90 |
$40.48K |
13,958 |
| 2024-07-15 |
Link David Charles |
Director |
Concesión de RSU |
9,305 |
$2.90 |
$26.98K |
9,305 |
| 2024-07-15 |
Sullivan Eddie Joe |
President |
Concesión de RSU |
4,447 |
$2.90 |
$12.9K |
4,447 |
| 2024-07-15 |
Giberson Scott |
Director |
Concesión de RSU |
20,000 |
$2.90 |
$58K |
20,000 |
| 2024-06-04 |
Conley Mark William |
See Remarks |
Disposición |
25,000 |
$4.79 |
$119.75K |
- |
| 2024-05-03 |
Skyler Jay S |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-02-21 |
Reich Samuel J |
CEO & Executive Chairman |
Concesión de RSU |
434,000 |
$5.17 |
$2.24M |
434,000 |
| 2024-02-21 |
Kropotova Alexandra |
Chief Medical Officer |
Concesión de RSU |
140,000 |
$5.17 |
$723.8K |
140,000 |
| 2024-02-21 |
Sullivan Eddie Joe |
President |
Concesión de RSU |
190,000 |
$5.17 |
$982.3K |
190,000 |
| 2024-02-21 |
Bausch Christoph Lawrence |
Chief Operating Officer |
Concesión de RSU |
140,000 |
$5.17 |
$723.8K |
140,000 |
| 2024-02-21 |
King Michael |
Chief Financial Officer |
Concesión de RSU |
115,000 |
$5.17 |
$594.55K |
115,000 |
| 2023-12-07 |
Sullivan Eddie Joe |
Chief Executive Officer |
Compra Informativa |
1,740 |
$0.88 |
$1.53K |
5,232,304 |
| 2023-11-30 |
King Michael |
Chief Financial Officer |
Compra Informativa |
5,000 |
$0.90 |
$4.5K |
5,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
